PRA

PRA names VP, psychiatric and scientific affairs

Friday, August 19, 2011 11:04 AM

PRA has named Dr. Frederick T. Lewis, D.O. vice president, psychiatry and scientific affairs in its therapeutic expertise group. Lewis will provide medical and scientific support for PRA project teams and guidance to clients in all aspects of clinical drug development.

More... »

PRA on the block, too?

Monday, August 8, 2011 08:02 AM

There was much hoopla made about PPD possibly being for sale after the Wall Street Journal published a story saying as much in mid-July. But what about its smaller competitor, PRA International?

More... »

PRA International acquires Kinship Technologies

Friday, May 20, 2011 11:06 AM

CRO PRA International has acquired Kinship Technologies, an India-based software developer and services company. PRA will obtain Kinship's industry changing system, EXACT, and is integrating the Kinship team to accelerate the development of technology solutions to enhance PRA's service delivery and reshape trial management.

More... »

Speculation flies over Logical Therapeutics as sites report non-payment for services

Monday, April 18, 2011 08:16 AM

Multiple investigative sites have been unable to collect payment from CRO PRA International for recent work they conducted on a phase IIb/III trial for Logical Therapeutics, a Waltham, Mass.-based biotechnology company developing a non-steroidal anti-inflammatory drug (NSAID), according to several independent sources.

More... »

Four clinical research firms become one global services organization to target niche areas

Monday, September 20, 2010 07:18 AM

Four small and mid-sized clinical research service companies—Averion International, Trio Clinical Research, Fulcrum Pharma and Clin-Research/ADDPLAN—have merged into one global biopharmaceutical and medical device development services organization that will focus on niche areas, including adaptive trials and new technologies, which can help sponsors make decisions about their drug candidates faster.

More... »

Victoria University launches Clinical Research Diploma

Wednesday, July 14, 2010 08:30 AM

Victoria University has launched a new post-graduate diploma in clinical research, claiming to be the only qualification of its kind in New Zealand, as part of a wider partnership on research, teaching and technology transfer with the Capital & Coast District Health Board (C&C DHB). The diploma is a distance learning course that will provide clinical researchers with, among other things, the capabilities to pursue drug development and conduct clinical trials, and will be taught mostly online by the university’s staff, together with clinicians from the C&C DHB and the Medical Research Institute of New Zealand. According to the university, its Postgraduate Diploma in Clinical Research, which begins in July, “takes the best of both the academic and clinical health worlds to strengthen clinical research.” U.S.-based CRO PRA International recently opened in New Zealand, saying the country was a key location for clinical studies in skin cancer, multiple sclerosis and asthma. PRA cited traditionally high recruitment rates across major therapeutic areas such as cardiology, respiratory diseases and gastrointestinal conditions; an efficient regulatory environment; and counter-seasonality for trials involving allergies or influenza.

More... »

PRA International Opens Phase I Facility in Hungary

Friday, July 2, 2010 08:03 AM

PRA International, a global CRO, opened a phase I facility in Budapest, Hungary that will provide “unit-on-demand” service.

More... »

PRA Expands into New Zealand

Wednesday, April 21, 2010 09:15 AM

PRA International expanded its Asia-Pacific operations into New Zealand, hiring staff there and establishing a legal entity. The New Zealand staff will work closely with PRA’s office in Sydney, Australia. New Zealand is a key research location for studies in skin cancer, multiple sclerosis, and asthma, the CRO said. The country is known for high recruitment rates, an efficient regulatory environment and counter seasonality—which is advantageous to influenza and allergy studies.

More... »

PRA Partners with Oncopartners in Brazil

Friday, January 29, 2010 07:57 AM

In an effort to speed up oncology trials in Latin America, PRA International entered into a partnership agreement with Oncopartners, a Latin American oncology development company, and its exclusive partner IBPC, a non-profit oncology research network made up of Brazil’s largest public oncology hospitals.

More... »

ICON Founder to Retire as Board Chairman

Friday, December 18, 2009 07:23 AM

John Climax will retire as board chairman of Dublin-based contract research organization (CRO) ICON, effective December 31. Climax founded the company 19 years ago. He will remain as a board member, while Bruce Given steps into the role of chairman. Given, a healthcare products consultant, has served on ICON’s board for five years. Prior to becoming a consultant, he was president and CEO of Encysive Pharmaceuticals.

More... »